Evidence map›Paper›PMID 30467642›Full record

ArticleRadiation and environmental biophysics2019

Measurement of γ-H2AX foci, miRNA-101, and gene expression as a means to quantify radiation-absorbed dose in cancer patients who had undergone radiotherapy.

Venkateswarlu Raavi, J Surendran, K Karthik, Solomon F D Paul, K Thayalan, J Arunakaran, Perumal Venkatachalam

Abstract read
PubMed Publisher
In one paragraph

Article in Radiation and environmental biophysics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Venkateswarlu RaaviDepartment of Human Genetics, Sri Ramachandra Medical College and Research Institute (Deemed to be University), Porur, Chennai, 600 116, India.
J SurendranDepartment of Radiation Oncology, Kamakshi Memorial Hospital, Pallikaranai, Chennai, 600 100, India.
K KarthikDepartment of Human Genetics, Sri Ramachandra Medical College and Research Institute (Deemed to be University), Porur, Chennai, 600 116, India.
Solomon F D PaulDepartment of Human Genetics, Sri Ramachandra Medical College and Research Institute (Deemed to be University), Porur, Chennai, 600 116, India.
K ThayalanDepartment of Radiation Oncology, Kamakshi Memorial Hospital, Pallikaranai, Chennai, 600 100, India.
J ArunakaranDepartment of Endocrinology, Dr. ALM PGIBMS, University of Madras, Taramani, Chennai, 600 113, India.
Perumal VenkatachalamDepartment of Human Genetics, Sri Ramachandra Medical College and Research Institute (Deemed to be University), Porur, Chennai, 600 116, India. venkip@yahoo.com.ORCID 0000-0003-2152-2003
Sri Ramachandra Institute of Higher Education and Research · INDr. Kamakshi Memorial Hospital · INUniversity of Madras · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiological accidents and nuclear terrorism pose an increased threat to members of the public who, following such an event, would need to be assessed for medical care by fast triage. Assay methods such as chromosome aberrations (CA), cytokinesis-block micronucleus (CBMN) and fluorescence in situ hybridization (FISH) techniques have been well established for dose estimation and their potential for handling more samples has also been proved with automation. However, culturing of lymphocytes is an inevitable step, which limits the potential of these markers for triage. In vitro analysis of gamma-H2AX (γ-H2AX), gene and microRNA (miRNA) markers do not require culturing of lymphocytes, and as such have been suggested as attractive tools for triage. Despite studies reporting in vitro dose-response curves, limited evidence is available evaluating the suitability of these assays in real situations. In this study, we have measured the absorbed dose using γ-H2AX, gene (GADD45A, FDXR, and CDKN1A) and miRNA-101 expression in blood samples of cancer patients (n = 20) who had undergone partial-body radiotherapy and compared with the derived equivalent whole-body doses (EWBD). The obtained results from all patients showed a significant (p < 0.05) increase of γ-H2AX foci in post-irradiated as compared to pre-irradiated samples. Moreover, estimated doses using γ-H2AX foci showed a correlation with the derived EWBD (r

Indexed as

Radiation DosageCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21Dose-Response Relationship, RadiationFemaleGADD45 ProteinsGene Expression Regulation, NeoplasticHistonesHumansLymphocytesMaleMicroRNAsMiddle AgedNeoplasmsCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21GADD45A protein, humanGADD45 ProteinsH2AX protein, humanHistonesMicroRNAsMIRN101 microRNA, humanBiomarkersGene expressionMicroRNARadiotherapyγ-H2AX foci

Identifiers

PMID30467642
OpenAlexW2901733995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.